Fluorescent biosensors for high throughput screening of protein kinase inhibitors

Biotechnology Journal

Volumn 9, Issue 2, 2014, Pages 253-265

  Prével, Camille ^a   Pellerano, Morgan ^a   Van, Thi Nhu Ngoc ^a   Morris, May C ^a  

^a Centre National de la Recherche Scientifique   (France)

Author keywords

Drug Discovery; Fluorescent Biosensor; High Throughput Screening; Inhibitor; Protein Kinase

Indexed keywords

DRUG DISCOVERY; FLUORESCENT BIOSENSOR; HIGH THROUGHPUT SCREENING; INHIBITOR; PROTEIN KINASE;

ANIMALS; BIOSENSING TECHNIQUES; FLUORESCENT DYES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MICE; PROTEIN KINASE INHIBITORS;

EID: 84895074355     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201300196     Document Type: Review

References (101)

1. Weissleder, R., Pittet, M. J., Imaging in the era of molecular oncology. Nature 2008, 452, 580-589.
2. Zhang, J., Campbell, R. E., Ting, A. Y., Tsien, R. Y., Creating New Fluorescent Probes for Cell Biology. Nat. Rev. Mol. Cell. Biol. 2002, 3, 906-918.
3. Chudakov, D. M., Matz, M. V., Lukyanov, S., Lukyanov, K. A., Fluorescent proteins and their applications in imaging living cells and tissues. Physiol. Rev. 2010, 90, 1103-1163.
4. Lavis, L. D., Raines, R. T., Bright ideas for chemical biology. ACS Chem. Biol. 2008, 3, 142-155.
5. Loving, G. S., Sainlos, M., Imperiali, B., Monitoring protein interactions and dynamics with solvatochromic fluorophores. Trends Biotechnol. 2010, 28, 73-83.
6. Ibraheem, A., Campbell, R. E., Designs and applications of fluorescent protein-based biosensors. Curr. Opin. Chem. Biol. 2010, 14, 30-36.
7. Palmer, A. E., Qin, Y., Park, J. G., McCombs, J. E., Design and application of genetically encoded biosensors. Trends Biotechnol. 2011, 29, 144-152.
8. Wang, H., Nakata, E., Hamachi, I., Recent progress in strategies for the creation of protein-based fluorescent biosensors. Chembiochem 2009, 10, 2560-2577.
9. Pazos, E., Vázquez, O., Mascareñas, J. L., Vázquez, M. E., Peptide-based fluorescent biosensors. Chem. Soc. Rev. 2009, 38, 3348-3359.
10. Morris, M. C., Fluorescent biosensors of intracellular targets from genetically encoded reporters to modular polypeptide probes. Cell. Biochem. Biophys. 2010, 56, 19-37.
11. Morris, M. C., Fluorescent Biosensors for Cancer Cell Imaging and Diagnostics. Biosensors and Cancer, Preedy, V., Hunter, J. (Eds.), CRC press, Science Publishers, 2012, pp. 101-124.
12. Morris, M. C., Fluorescent biosensors - promises for personalized medicine. J. Biosensors Bioelectron. OMICS, 2012, 3, 3.
13. Morris, M. C., Fluorescence-Based Biosensors - concepts and applications, Morris, M. C. (Ed.), Progr. Mol. Biol. Trans. Science, Vol. 113, Elsevier Press, 2013, pp. 1-414.
14. Giuliano, K. A., Taylor, D. L., Fluorescent-protein biosensors: New tools for drug discovery. Trends Biotechnol. 1998, 16, 135-140.
15. Hanson, G. T., Hanson, B. J., Fluorescent probes for cellular assays. Comb. Chem. High Throughput Screen. 2008, 11, 505-513.
16. Taylor, D. L., A personal perspective on high-content screening (HCS): From the beginning. J. Biomol. Screen. 2010, 15, 720-725.
17. Wolff, M., Wiedenmann, J., Nienhaus, G. U., Valler, M. et al., Novel fluorescent proteins for high-content screening. Drug Discov. Today. 2006, 11, 1054-1060.
18. Lang, P., Yeow, K., Nichols, A., Scheer, A., Cellular imaging in drug discovery. Nat. Rev. Drug Discov. 2006, 5, 343-356.
19. Carpenter, A. E., Image-based chemical screening. Nat. Chem. Biol. 2007, 3, 461-465.
20. Zanella, F., Lorens, J. B., Link, W., High content screening: seeing is believing, Trends Biotechnol. 2010, 28, 237-245.
21. Piljic, A., Schultz, C., Simultaneous recording of multiple cellular events by FRET. ACS Chem. Biol. 2008, 3, 156-160.
22. Carlson, H. J., Campbell, R. E., Genetically encoded FRET-based biosensors for multiparameter fluorescence imaging. Curr. Opin. Biotechnol. 2009, 20, 19-27.
23. Welch, C. M., Elliott, H., Danuser, G., Hahn, K. M., Imaging the coordination of multiple signalling activities in living cells. Nat. Rev. Mol. Cell Biol. 2011, 12, 749-756.
24. Nobis, M., McGhee, E.J., Morton, J. P., Schwarz, J. P., Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer. Cancer Res. 2013, 73, 4674-4686.
25. Fan-Minogue, H., Cao, Z., Paulmurugan, R., Chan, C. T., Massoud, T. F. et al., Noninvasive molecular imaging of c-Myc activation in living mice. Proc. Natl. Acad. Sci. USA 2010, 107, 15892-15897.
26. Zhang, J. H., Chung, T. D., Oldenburg, K. R., A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999, 4, 67-73.
27. Inglese, J., Shamu, C. E., Guy, R. K., Reporting data from high-throughput screening of small-molecule libraries. Nat. Chem. Biol. 2007, 3, 438-441.
28. Sui, Y., Wu, Z., Alternative statistical parameter for high-throughput screening assay quality assessment. J. Biomol. Screen. 2007, 12, 229-234.
29. Allen, M. D., DiPilato, L. M., Rahdar, M., Ren, Y. R. et al., Reading dynamic kinase activity in living cells for high-throughput screening. ACS Chem. Biol. 2006, 1, 371-376.
30. Zaman, G. J., Garritsen, A., de Boer, T., van Boeckel, C. A., Fluorescence assays for high-throughput screening of protein kinases. Comb. Chem. High Throughput Screen. 2003, 6, 313-320.
31. von Ahsen, O., Bömer, U., High throughput screening for kinase inhibitors. ChemBioChem 2005, 6, 481-490.
32. Vendrell, M., Zhai, D., Er, J. C., Chang, Y. T., Combinatorial strategies in fluorescent probe development. Chem Rev. 2012, 112, 4391-4420.
33. Ljosa, V., Carpenter, A. E., High-throughput screens for fluorescent dye discovery. Trends Biotechnol. 2008, 26, 527-530.
34. Inglese, J., Johnson, R. L., Simeonov, A., Xia, M. et al., High-throughput screening assays for the identification of chemical probes. Nat Chem Biol. 2007, 3, 466-479.
35. Berg, R. H., Beachy, R. N., Fluorescent protein applications in plants. Methods Cell Biol. 2008, 85, 153-177.
36. Nicholson, R. L., Welch, M., Ladlow, M., Spring, D. R., Small-molecule screening: advances in microarraying and cell-imaging technologies. ACS Chem. Biol. 2007, 2, 24-30.
37. O'Rourke, E. J., Conery, A. L., Moy, T. I., Whole-animal high-throughput screens: the C. elegans model. Methods Mol. Biol. 2009, 486, 57-75.
38. Blackburn, J. S., Liu, S., Raimondi, A. R., Ignatius, M. S. et al., High-throughput imaging of adult fluorescent zebrafish with an LED fluorescence macroscope. Nat. Protoc. 2011, 6, 229-241.
39. Kobayashi, H., Longmire, M. R., Ogawa, M., Choyke, P. L., Rational chemical design of the next generation of molecular imaging probes based on physics and biology: Mixing modalities, colors and signals. Chem. Soc. Rev. 2011, 40, 4626-4648.
40. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. et al., The protein kinase complement of the human genome. Science 2002, 298, 1912-1934.
41. Hunter, T., A thousand and one protein kinases. Cell 1987, 50, 823-829.
42. Cohen, P., Protein kinases - the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 2002, 1, 309-315.
43. Johnson, L., Protein kinases and their therapeutic exploitation. Biochem. Soc. Trans. 2007, 35, 7-11.
44. Zhang, J., Yang, P. L., Gray, N. S., Targeting cancer with small molecule kinase inhibitors. Nat. Rev. Cancer. 2009, 9, 28-39.
45. Taylor, S. S., Radzio-Andzelm, E., Three protein kinase structures define a common motif. Structure 1994, 2, 345-355.
46. Véron, M., Radzio-Andzelm, E., Tsigelny, I., Taylor, S. S., Protein kinases share a common structural motif outside the conserved catalytic domain. Cell Mol. Biol. 1994, 40, 587-596.
47. Johnson, L. N., Noble, M. E., Owen, D. J., Active and inactive protein kinases: structural basis for regulation. Cell 1996, 85, 149-158.
48. Huse, M., Kuriyan, J., The conformational plasticity of protein kinases. Cell 2002, 109, 275-282.
49. Ubersax, J. A., Ferrell, J. E. Jr., Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 2007, 8, 530-541.
50. Turk, B. E., Understanding and exploiting substrate recognition by protein kinases. Curr. Opin. Chem. Biol. 2008, 12, 4-10.
51. Nolen, B., Taylor, S., Ghosh, G., Regulation of protein kinases: controlling activity through activation segment conformation. Mol. Cell 2004, 15, 661-675.
52. Taylor, S. S., Yang, J., Wu, J., Haste, N. M. et al., PKA: A portrait of protein kinase dynamics. Biochim. Biophys. Acta 2004, 1697, 259-269.
53. Cohen, P., Alessi, D. R., Kinase drug discovery - what's next in the field? ACS Chem. Biol. 2013, 8, 96-104.
54. Aimes, R. T., Hemmer, W., Taylor, S. S., Serine-53 at the tip of the glycine-rich loop of cAMP-dependent protein kinase: role in catalysis, P-site specificity, and interaction with inhibitors. Biochemistry 2000, 39, 8325-8332.
55. Knighton, D. R., Zheng, J. H., Ten Eyck, L. F., Xuong, N. H. et al., Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 1991, 253, 414-420.
56. Fang, Z., Grütter, C., Rauh, D., Strategies for the Selective Regulation of Kinases with Allosteric Modulators: Exploiting Exclusive Structural Features. ACS Chem. Biol. 2013, 8, 58-70.
57. Eglen, R. M., Reisine, T., Human kinome drug discovery and the emerging importance of atypical allosteric inhibitors. Expert Opin. Drug. Discov. 2010, 5, 277-290.
58. Liu, Y., Gray, N. S., Rational design of inhibitors that bind to inactive kinase conformations. Nat. Chem. Biol. 2006, 2, 358-364.
59. Pargellis, C., Tong, L., Churchill, L., Cirillo, P. F. et al., Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat. Struct. Biol. 2002, 9, 268-272.
60. Tarrant, M. K., Cole, A. P., The chemical biology of protein phosphorylation. Annu. Rev. Biochem. 2009, 78, 797-825.
61. Chen, C. A., Yeh, R. H., Yan, X., Lawrence, D. S., Biosensors of protein kinase action: From in vitro assays to living cells. Biochim. Biophys. Acta 2004, 1697, 39-51.
62. Lawrence, D. S., Wang, Q., Seeing is believing: Peptide-based fluorescent sensors of protein tyrosine kinase activity. Chembiochem 2007, 8, 373-378.
63. Sharma, V., Wang, Q., Lawrence, D. S., Peptide-based fluorescent sensors of protein kinase activity: Design and applications. Biochim. Biophys. Acta. 2008, 1784, 94-99.
64. Zhang, J., Allen, M. D., FRET-based biosensors for protein kinases: Illuminating the kinome. Mol. Biosystems 2007, 3, 759-765.
65. Gonzalez-Vera, J. A., Probing the kinome in real time with fluorescent peptides. Chem. Soc. Rev. 2012, 41, 1652-1664.
66. Van, T. N. N., Morris, M. C., Fluorescent sensors of protein kinases: From basics to biomedical applications. Prog. Mol. Biol. Transl. Sci. 2013, 113, 217-274.
67. Morris, M. C., Fluorescent Biosensors - Probing protein kinase function in cancer and drug discovery. Biochim. Biophys. Acta. 2013, 1834, 1387-1395.
68. Giuliano, K. A., Chen, Y. T., Haskins, J. R., Positional biosensors: A new tool for high content screening. Modern Drug Discov. 2003, 6, 33-37.
69. Kurzawa L, Morris M. C. Cell-cycle markers and biosensors. Chembiochem 2010, 11, 1037-1047.
70. O'Dowd, B. F., Alijaniaram, M. Ji. X., Nguyen, T., Eglen, R. M., George, S. R., Using ligand-induced conformational change to screen for compounds targeting G-protein-coupled receptors. J. Biomol. Screen. 2007, 12, 175-85.
71. Dudgeon, D. D., Shinde, S., Hua, Y., Shun, T. Y. et al., Implementation of a 220, 000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits. J. Biomol. Screen. 2010, 15, 766-782.
72. Antczak, C., Mahida, J. P., Bhinder, B., Calder, P. A., Djaballah, H., A high-content biosensor-based screen identifies cell-permeable activators and inhibitors of EGFR function: Implications in drug discovery. J. Biomol. Screen. 2012, 17, 885-899.
73. Taylor, S. S., Zhang, P., Steichen, J. M., Keshwani, M. M. et al., PKA: Lessons learned after twenty years. Biochim. Biophys. Acta 2013, 1834, 1271-1278.
74. Mizutani, T., Kondo, T., Darmanin, S., Tsuda, M. et al., A novel FRET-based biosensor for the measurement of BCR-ABL activity and its response to drugs in living cells. Clin. Cancer Res. 2010, 16, 3964-3975.
75. Lu, S., Wang, Y., Fluorescence resonance energy transfer biosensors for cancer detection and evaluation of drug efficacy. Clin. Cancer Res. 2010, 16, 3822-3824.
76. Tunceroglu, A., Matsuda, M., Birge, R. B., Real-time fluorescent resonance energy transfer analysis to monitor drug resistance in chronic myelogenous leukemia. Mol. Cancer Ther. 2010, 9, 3065-3073.
77. Shults, M. D., Janes, K. A., Lauffenburger, D. A., Imperiali, B., A multiplexed homogeneous fluorescence-based assay for protein kinase activity in cell lysates. Nat. Methods 2005, 2, 277-283.
78. Shults, M. D., Carrico-Moniz, D., Imperiali, B., Optimal Sox-based fluorescent chemosensor design for serine/threonine protein kinases. Anal. Biochem. 2006, 352, 198-207.
79. Luković, E., Vogel Taylor, E., Imperiali, B., Monitoring protein kinases in cellular media with highly selective chimeric reporters. Angew. Chem. Int. Ed. Engl. 2009, 48, 6828-6831.
80. Stains, C. I., Luković, E., Imperiali, B., A p38α-selective chemosensor for use in unfractionated cell lysates. ACS Chem. Biol. 2011, 6, 101-105.
81. Wang, Q., Zimmerman, E. I., Toutchkine, A., Martin, T. D. et al., Multicolor monitoring of dysregulated protein kinases in chronic myelogenous leukemia. ACS Chem. Biol. 2010, 5, 887-895.
82. Simard, J. R., Getlik, M., Grütter, C., Pawar, V. et al., Development of a Fluorescent-tagged kinase assay system for detection and characterization of allosteric kinase inhibitors. JACS 2009, 131, 13286-13296.
83. Simard, J. R. et al., High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha. J. Am. Chem. Soc. 2009, 131, 18478-18488.
84. Simard, J. R., Getlik, M., Grütter, C., Schneider, R. et al., Fluorophore labelling of the glycine-rich loop as a method of identifying inhibitors that bind to active and inactive kinase conformations. JACS 2010, 132, 4152-4160.
85. Simard, J. R., Klüter, S., Grütter, C., Getlik, M. et al., A new screening assay for allosteric inhibitors of cSrc. Nat. Chem. Biol. 2009, 5, 394-396.
86. Getlik, M., Simard, J. R., Termathe, M., Grütter, C. et al., Fluorophore labelled kinase detects ligands that bind within the MAPK insert of p38a kinase. PLoS One 2012, 7, e39713.
87. Zhang, J., Adrian, F. J., Jahnke, W., Cowan-Jacob, S. W. et al., Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature 2010, 463, 501-506.
88. Schneider, R., Becker, R., Simard, J. R., Getlik, M. et al., Direct binding assay for the detection of Type IV allosteric Inhibitors of Abl. JACS 2012, 134, 9138-9141.
89. Morgan, D. O., Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 1997, 13, 261-291.
90. Malumbres M, Barbacid M. To cycle or not to cycle: A critical decision in cancer. Nat. Rev. Cancer 2001, 1, 222-231.
91. Lapenna, S., Giordano, A., Cell cycle kinases as therapeutic targets for cancer. Nat. Rev. Drug Discov. 2009, 8, 547-566.
92. Noble, M., Barrett, P., Endicott, J., Johnson, L. et al., Exploiting structural principles to design cyclin-dependent kinase inhibitors. Biochim. Biophys. Acta 2005, 1754, 58-64.
93. Lolli, G., Structural dissection of cyclin dependent kinases regulation and protein recognition properties. Cell Cycle 2010, 9, 1551-1561.
94. De Azevedo, W. F., Leclerc, S., Meijer, L., Strand, M. et al., Inhibition of cyclin-dependent kinases by purine analogues: Crystal structure of human cdk2 complexed with roscovitine. Eur. J. Biochem. 1997, 243, 518-526.
95. Vassilev, L. T., Tovar, C., Chen, S., Knezevic, D. et al., Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1. Proc. Natl. Acad. Sci. USA 2006, 103, 10660-10665.
96. Mendoza, N., Fong, S., Marsters, J., Koeppen, H. et al., Selective cyclin-dependent kinase 2/Cyclin A antagonists that differ from ATP site inhibitors block tumor growth. Cancer Res. 2003, 63, 1020-1024.
97. Canela, N., Orzaez, M., Fucho, R., Mateo, F. et al., Identification of an Hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A. J. Biol. Chem. 2006, 281, 35942-35953.
98. Bagella, L., Sun, A., Tonini, T., Abbadessa, G. et al., A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumour growth reduction in vivo. Oncogene 2007, 26, 1829-1839.
99. Gondeau, C., Gerbal-Chaloin, S., Bello, P., Aldrian-Herrada, G. et al., Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation. J. Biol. Chem. 2005, 280, 13793-13800.
100. Martin, M. P., Alam, R., Betzi, S., Ingles, D. J. et al., A novel approach to the discovery of small-molecule ligands of CDK2. Chembiochem 2012, 13, 2128-2136.
101. Tian, H., Ip, L., Luo, H., Chang, D. C., Luo, K. Q., A high throughput drug screen based on fluorescence resonance energy transfer (FRET) for anticancer activity of compounds from herbal medicine. Br. J. Pharmacol. 2007, 150, 321-334.